- ¥3bn
- ¥3bn
- ¥6bn
- 57
- 28
- 33
- 30
Annual income statement for Medical Net, fiscal year end - May 31st, JPY millions except per share, conversion factor applied.
C2021 May 31st | R2022 May 31st | 2023 May 31st | 2024 May 31st | 2025 May 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
| Standards: | JAS | JAS | JAS | — | JAS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 2,905 | 3,746 | 4,501 | 5,252 | 6,078 |
| Cost of Revenue | |||||
| Gross Profit | 1,178 | 1,460 | 1,781 | 1,841 | 1,966 |
| Selling / General / Administrative Expenses | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 2,652 | 3,216 | 4,305 | 5,129 | 6,441 |
| Operating Profit | 253 | 529 | 196 | 123 | -364 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 254 | 534 | 251 | 153 | 25.2 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 138 | 396 | 109 | 26.4 | -37.6 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 130 | 380 | 116 | 5.96 | -68.1 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 130 | 380 | 116 | 5.96 | -68.1 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 22 | 38.1 | 26.9 | 16.6 | 5.46 |
| Dividends per Share | |||||
| Special Dividends per Share |